Isolation of cholesterol-dependent, multidrug-resistant Candida glabrata strains from blood cultures of a candidemia patient in Kuwait
暂无分享,去创建一个
[1] B. Wickes,et al. Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure , 2013, Antimicrobial Agents and Chemotherapy.
[2] F. Zaini,et al. Overexpression of aldo-keto-reductase in azole-resistant clinical isolates of Candida glabrata determined by cDNA-AFLP , 2013, DARU Journal of Pharmaceutical Sciences.
[3] M. Pfaller,et al. Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012 , 2012, Journal of Clinical Microbiology.
[4] D. Kelly,et al. Facultative Sterol Uptake in an Ergosterol-Deficient Clinical Isolate of Candida glabrata Harboring a Missense Mutation in ERG11 and Exhibiting Cross-Resistance to Azoles and Amphotericin B , 2012, Antimicrobial Agents and Chemotherapy.
[5] M. Pfaller,et al. The changing epidemiology of healthcare-associated candidemia over three decades. , 2012, Diagnostic microbiology and infectious disease.
[6] M. Castanheira,et al. Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata , 2012, Journal of Clinical Microbiology.
[7] Suhail Ahmad,et al. Prevalence of Candida dubliniensis among cancer patients in Kuwait: a 5‐year retrospective study , 2011, Mycoses.
[8] T. Myers,et al. Microarray and Molecular Analyses of the Azole Resistance Mechanism in Candida glabrata Oropharyngeal Isolates , 2010, Antimicrobial Agents and Chemotherapy.
[9] T. Boekhout,et al. Cryptococcus randhawai sp. nov., a novel anamorphic basidiomycetous yeast isolated from tree trunk hollow of Ficus religiosa (peepal tree) from New Delhi, India , 2010, Antonie van Leeuwenhoek.
[10] Suhail Ahmad,et al. Rapid molecular differentiation and genotypic heterogeneity among Candida parapsilosis and Candida orthopsilosis strains isolated from clinical specimens in Kuwait. , 2009, Journal of medical microbiology.
[11] J. Sobel,et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] Z. Khan,et al. Emergence of Resistance to Amphotericin B and Triazoles in Candida glabrata Vaginal Isolates in a Case of Recurrent Vaginitis , 2008, Journal of chemotherapy.
[13] J. Guarro,et al. Cholesterol dependent and Amphotericin B resistant isolates of a Candida glabrata strain from an Intensive Care Unit patient. , 2008, Medical mycology.
[14] R. Homayouni,et al. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome‐wide expression studies , 2006, Molecular microbiology.
[15] M. Arendrup,et al. Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] M. Bard,et al. Sterol uptake in Candida glabrata: rescue of sterol auxotrophic strains. , 2005, Diagnostic microbiology and infectious disease.
[17] A. Breathnach,et al. Isolation of cholesterol-dependent Candida glabrata from clinical specimens. , 2005, Diagnostic microbiology and infectious disease.
[18] G. Fadda,et al. Mechanisms of Azole Resistance in Clinical Isolates of Candida glabrata Collected during a Hospital Survey of Antifungal Resistance , 2005, Antimicrobial Agents and Chemotherapy.
[19] J. Swartz,et al. Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility , 1995, Antimicrobial agents and chemotherapy.
[20] M. Pfaller,et al. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. , 2012, The American journal of medicine.
[21] C. Andrzejewski,et al. BMC Infectious Diseases , 2006 .